FDA pharmacologic class

Hydrolytic Lysosomal Glucocerebroside-specific Enzyme

3 medicines are in FDA's class of hydrolytic lysosomal glucocerebroside-specific enzymes: imiglucerase (Cerezyme), taliglucerase alfa (Elelyso) and velaglucerase alfa (Vpriv). 0 of the 3 are listed from generic labelers (FDA NDC Directory, October 8, 2026).

Which medicines are hydrolytic lysosomal glucocerebroside-specific enzyme?

Recalls: FDA enforcement reports, 2012 on
Medicine	Brand names	Generic labelers (all forms)	Pharmacy cost	Boxed warning	Shortage	Recalls since 2012
Imiglucerase	Cerezyme	none listed	n/a	Yes	No current entry	0
Taliglucerase alfa	Elelyso	none listed	n/a	Yes	No current entry	2
Velaglucerase alfa	Vpriv	none listed	n/a	Yes	No current entry	1

Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)

What next?

Every drug class
Medicines A to Z